CVRX
CVRx, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.04
+1.10%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.7x
Market Cap
$81.07M
MomentumView details →
1D Return
+1.10%
YTD Return
−56.76%
RSI (14)
41.5
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.7x
Market Cap
$81.07M
RSI (14)
41.5
MomentumView details →
1D Return
+1.10%
YTD Return
−56.76%
SummaryUpdated Jun 1, 2026
CVRx, Inc. (NASDAQ:CVRX) is a commercial-stage medical device company founded in 2000 and headquartered in Minneapolis, Minnesota. The company went public in June 2021 and specializes in developing neuromodulation solutions for cardiovascular diseases. CVRx has established itself as a pioneer in the emerging field of cardiovascular neuromodulation, focusing primarily on treating heart failure through its flagship Barostim device. After more than two decades of development and clinical testing, the company has successfully commercialized its technology and is actively expanding its market presence in the United States and Europe.
Similar companies
Latest newsMore news →
Pomerantz LLP announced an investigation into CVRx, Inc. for potential securities fraud or unlawful business practices on behalf of investors.3d agoJorey Chernett, beneficial owner of more than 5.5% of CVRx's outstanding shares, delivered a letter to the CVRx Board urging it to launch an immediate process to sell the company to a strategic acquirer.11d agoJohnson Fistel, PLLP announced an investigation into CVRx, Inc. and certain executive officers for potential violations of state or federal securities laws related to investor losses.28d ago